Treasury
CH Biotech R&D to Issue NT$700 Million Bonds
CH Biotech R&D (TPE:6534) board approved plans to issue NT$700 million of its first domestic secured convertible bonds, according to a Wednesday Taiwan Stock Exchange filing.The three-year bonds will have a face value of NT$100,000 each and a zero coupon rate. The tentative issue price is set at 100% to 101% of face value.The bonds will be secured by a bank guarantee and offered publicly through a book-building process.CH Biotech said proceeds will be used to repay bank loans and strengthen working capital.
TPE:6534
